Sci Show: L-arginine, an off-patent, low cost and safe nutraceutical, reduces need for respiratory support and length of hospitalisation for COVID-19 by almost 50% in a recent RCT published in the Lancet

Saturday, October 9, 2021

L-arginine, an off-patent, low cost and safe nutraceutical, reduces need for respiratory support and length of hospitalisation for COVID-19 by almost 50% in a recent RCT published in the Lancet

https://ift.tt/3tt5dnn via /r/science https://ift.tt/3uXYwdD

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)